Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jeffrey A. LaRose"'
Autor:
Gretel Monreal, Steven C. Koenig, Mustafa Ertan Taskin, Charles Shambaugh, Jeffrey A. LaRose, Mark S. Slaughter
Publikováno v:
ASAIO Journal.
Autor:
Neil Voskoboynikov, Jeffrey A. LaRose, Michael C. Brown, Nathalie J. Nunez, Carlos Reyes, Daniel Tamez, Katherine Chorpenning, Daniel Burkhoff
Publikováno v:
ASAIO Journal. 62:15-19
Controller algorithms are an important feature for assessment of ventricular assist device performance. Flow estimation is one algorithm implemented in the HeartWare continuous-flow ventricular assist device pump system. This parameter estimates flow
Autor:
Daniel Tamez, Michael Ashenuga, Katherine Chorpenning, Charles R. Shambaugh, M. Ertan Taskin, Anne E. Dierlam, Jeffrey A. LaRose, Carlos Reyes, Anson Cheung
Publikováno v:
Innovations (Philadelphia, Pa.)
Objective Ventricular assist device (VAD) miniaturization is one design trend that may result in less-invasive implantation techniques and more versatility with patient selection. The MVAD System is a miniature, continuous-flow device implanted in th
Autor:
Guruprasad A. Giridharan, Leslie C. Sherwood, Gretel Monreal, Kevin G. Soucy, Steven C. Koenig, Mark S. Slaughter, Charles R. Shambaugh, Katherine Chorpenning, Daniel Tamez, Jeffrey A. LaRose, Michael A. Sobieski
Publikováno v:
ASAIO Journal. 60:170-177
Implantation of ventricular assist devices (VADs) for the treatment of end-stage heart failure (HF) falls decidedly short of clinical demand, which exceeds 100,000 HF patients per year. Ventricular assist device implantation often requires major surg
Autor:
Michael S. Gossman, Indra J. Das, Joel D. Graham, Jeffrey A. LaRose, Dan Tamez, Len Coutinho, Chee-Wai Cheng
Publikováno v:
ASAIO Journal. 58:597-600
Inadequate research exists regarding testing of a ventricular assist device (VAD) for susceptibility to radiation damage. Specifically, minimal data are available to radiation oncologists prescribing treatment plans for patients with an implanted VAD
Publikováno v:
ASAIO Journal. 58:212-216
Improved outcomes and quality of life of heart failure patients have been reported with the use of left ventricular assist devices (LVADs). However, little information exists regarding devices in patients undergoing radiation cancer treatment. Two He
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 60(5)
As a result of stagnant heart transplantation rates, ventricular assist devices (VADs) have become a widely accepted therapy for the treatment of advanced-stage heart failure. Long-term reliability of VADs will become increasingly vital as the popula
Autor:
Edwin C. McGee, Eugene Breznock, Katherine Chorpenning, Jeffrey A. LaRose, Daniel Tamez, Michael C. Brown
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 33(4)
Objective The current design trend for left ventricular assist devices (LVADs) is miniaturization, which aims to increase the treatable patient population and enable new treatment indications by reducing surgical trauma and the complications associat
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 56(4)
Implantable left ventricular assist devices provide circulatory support for patients at risk of death from refractory, end-stage heart failure. Rotary blood pumps have been designed for increased reliability and smaller size for use in a broader popu
Autor:
Dan Tamez, Leslie C. Sherwood, M.A. Sobieski, Steven C. Koenig, Jeffrey A. LaRose, Guruprasad A. Giridharan, Mark S. Slaughter, S. Aggarwal
Publikováno v:
The Journal of Heart and Lung Transplantation. 29:S99-S100